Food, drugs, devices › Pharmedium Services, LLC
Drug recall: HYDROmorphone HCl in Sodium Chloride 0.9% in all doses, all strengths, and all packaging.
Pharmedium Services, LLC (Lake Forest, IL) initiated this drug recall on 27 Dec 2017; FDA lists 42 product records under event 78828, classified Class II.
FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 57% of the 343 drug enforcement events initiated in 2017 carry the same class.
Status: Terminated, terminated 7 May 2020. Initiation: voluntary: firm initiated. Pharmedium Services, LLC has 30 enforcement events on this register, with a median of 2 product records per event.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Pharmedium Services, LLC, Lake Forest, IL.
Reason for recall
"Lack of sterility assurance."
Distribution
"U.S.A. Nationwide"
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| D-0428-2018 | HYDROmorphone HCl in Sodium Chloride 0.9% in all doses, all strengths, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0429-2018 | Bupivacaine HCl in 0.9% Sodium Chloride in all doses, all strengths, and packaging. | 297 bags | Class II | Terminated | 28 Feb 2018 |
| D-0430-2018 | Fentanyl Citrate and Ropivacaine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0431-2018 | Fentanyl Citrate and Bupivacaine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0432-2018 | Ephedrine Sulfate in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0433-2018 | HYDROmorphone HCl Injection in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0434-2018 | Midazolam HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0435-2018 | Midazolam HCl in 5% Dextrose in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0436-2018 | Morphine Sulfate in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0437-2018 | Morphine Sulfate in 5% Dextrose in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0438-2018 | Lidocaine HCl in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0439-2018 | Fentanyl Citrate in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0440-2018 | Potassium Chloride in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0441-2018 | Ketamine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0442-2018 | Succinylcholine Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0443-2018 | Adenosine Injection in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0444-2018 | Dexamethasone Sodium Phosphate in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0445-2018 | Phenylephrine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0446-2018 | Potassium Chloride in 5% Dextrose in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0447-2018 | Labetalol HCl in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0448-2018 | Methadone HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0449-2018 | Midazolam HCl Injection in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0450-2018 | Fentanyl Citrate Injection in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0451-2018 | Ephedrine Sulfate Injection in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0452-2018 | Ketamine HCl Injection in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0453-2018 | Ropivacaine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0454-2018 | Glycopyrrolate in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0455-2018 | Lidocaine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0456-2018 | Atropine Sulfate Injection in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0457-2018 | HYDROmorphone HCl in 5% Dextrose in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0458-2018 | Ropivacaine HCl Injection in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0459-2018 | Nicardipine HCl in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0460-2018 | Labetalol HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0461-2018 | Neostigmine Methylsulfate Injection in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0462-2018 | Vecuronium Bromide in Sterile Water for Injection in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0463-2018 | Dexamethasone Sodium Phosphate added to 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0464-2018 | Esmolol HCl in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0465-2018 | Meperidine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0466-2018 | Methadone HCl Injection in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0467-2018 | Rocuronium Bromide in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0468-2018 | Dexamethasone Sodium Phosphate added to 5% Dextrose in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
| D-0469-2018 | Nicardipine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. | Unknown | Class II | Terminated | 28 Feb 2018 |
Context
Other enforcement events for Pharmedium Services, LLC
All 30 events for Pharmedium Services, LLC
Questions and answers
Why was this drug recalled?
FDA's record gives the reason for recall as: "Lack of sterility assurance."
What does Class II mean?
FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Where was the product distributed?
FDA's distribution pattern field reads: "U.S.A. Nationwide"
Is the recall still ongoing?
FDA lists the status as Terminated; the termination date is 7 May 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.